CHARTWELL NEWS
  • BioCryst Pharmaceuticals Appoints Salisa Hauptmann, MPH as SVP, Regulatory Affairs

    Chartwell Partners is pleased to announce the appointment of Salisa Hauptmann, MPH, as Senior Vice President, Regulatory Affairs for BioCryst Pharmaceuticals, a company pioneering the discovery, development and commercialization of oral, small molecule medicines to treat rare diseases. Salisa brings more than 25 years of global regulatory expertise to BioCryst, including significant work with rare,…

  • Addus HomeCare adds Veronica Hill-Milbourne and Esteban López, M.D. to their Board of Directors

    Chartwell Partners is pleased to announce that Veronica Hill-Milbourne and Esteban López, M.D. have been appointed to Addus HomeCare’s Board of Directors.   Ms. Hill-Milbourne is currently President and Chief Executive Officer of Spectrum Health Services, Inc., with executive oversight of three Federally Qualified Health Centers located in Philadelphia, Pennsylvania. She previously served as Chief…

  • Rare Disease Biotech Company, EryDel, names Esin Kosal, PhD as SVP, Regulatory Affairs

    Chartwell Partners is pleased to announce the recruitment of Esin Kosal, PhD as SVP, Regulatory Affairs for EryDel SpA, a global biotechnology company utilizing its proprietary red blood cell drug delivery technology to encapsulate small and large molecules into a patient’s own red blood cells which are then reinfused into that patient in a fast,…

  • Taysha adds Kathy Reape and Laura Sepp-Lorenzino to Board of Directors

    Chartwell Partners is honored to have been selected to partner with Taysha Gene Therapies on appointing new Board members: Kathy Reape, M.D., former Chief Medical Officer of Spark Therapeutics, and Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer of Intellia Therapeutics. Both women bring broad pharmaceutical industry experience and tremendous gene therapy expertise to Taysha, from leading…

  • Kolmac Outpatient Recovery selects Steve DeVore as President and CEO

    Chartwell Partners is pleased to announce that Steve DeVore has joined Kolmac Outpatient Recovery as President and CEO.  Mr. Devore brings to Kolmac extensive experience in various healthcare sectors previously serving as Chief Operating Officer with Light Wage Dental and Vice President of Operations with National Veterinary Associates.   Partnered with its private equity investor,…

  • Abode Healthcare names Daniel Schwartz as Chief Operating Officer

    Chartwell Partners is pleased to announce the hiring of Daniel Schwartz as the Chief Operating Officer for Abode Healthcare. Abode is a Summit Partners-backed provider of home health and hospice services with in excess of 30 programs spread across 11 states. Mr. Schwartz joins Abode with 30 years experience in the senior care industry which…

  • Adicet Bio Appoints Nick Harvey as Chief Financial Officer

    Chartwell Partners is pleased to announce the recruitment of Nick Harvey as Chief Financial Officer for Adicet Bio, a public biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Mr. Harvey joins Adicet most recently from Centrexion Therapeutics, a privately held biotechnology company, where he served as Executive…

  • Steven Silvers to join Express Flooring as Chief Operating Officer

    Chartwell Partners is pleased to announce that Steven Silvers has recently joined Express Flooring as their Chief Operating Officer.  Prior to joining Express Flooring, Mr. Silvers served as a Partner for C-Suite Financial Partners.   Express Flooring is market leader of residential and commercial flooring solutions located in the Southwest. Express Flooring offers its customers…

  • Diamond C appoints Mark Huddleston as Vice President of Operations

    Chartwell Partners is pleased to announce that Mark Huddleston has recently joined Diamond C as their Vice President of Operations. Prior to joining Diamond C, Mr. Huddleston served as the Vice President of Operations for TexTrail.   Diamond C is a family owned and operated Texas-based manufacturer that designs, manufacturers, and markets flat-bed trailers. Established…

  • US Anesthesia Partners selects Mike Spies as Chief Information Officer

    Chartwell Partners is pleased to announce that Mike Spies has recently joined US Anesthesia Partners (USAP) as their Chief Information Officer. Prior to joining USAP, Mr. Spies served as the Senior Vice President of Enterprise Data an Architecture for Apple Leisure Group.   US Anesthesia is the nation’s leading provider of high-quality anesthesia services. USAP…